WALTHAM, MA--(Marketwire - December 20, 2007) - EyeGate Pharma, a privately held, specialty pharmaceutical company pioneering the use of iontophoresis technology to safely and non-invasively deliver therapeutics for ocular indications, today announced that it has expanded its senior management team with the appointment of Remis Bistras, Ph.D., M.B.A, as Vice President, Business Development. Dr. Bistras is responsible for developing corporate strategies and overseeing all business and corporate development functions, including strategic collaborations, acquisitions and licensing.
